Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Business of Cannabis is a premier B2B media and data platform providing news, analysis, and commercial insights for the global cannabis industry. Founded in 2017 and based in Toronto, the company serves as a definitive source of information for professionals, investors, and policymakers navigating the complex regulatory and financial landscape of cannabis. In 2021, the company was acquired by Prohibition Partners, a leading UK-based cannabis data and intelligence firm, to expand its global reach. Business of Cannabis is widely recognized for its high-impact events, such as the Business of Cannabis: New York conference, and its focus on the intersection of policy, business, and healthcare within the sector. The platform offers a range of services including digital content, podcasts, and strategic networking opportunities for the cannabis ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Business of Cannabis.